hyaluronate

(redirected from Dextranomer)
Also found in: Medical, Wikipedia.

hyaluronate

[‚hī·ə′lu̇r·ə‚nāt]
(biochemistry)
A salt or ester of hyaluronic acid.
References in periodicals archive ?
These IBAs include autologous fat, cross-linked collagen, graphite-coated zirconium beads, polytetrafluroethylene, silicon, dimethylsulfoxide and ethylene vinyl alcohol copolymers, hyaluronic acid, dextranomer microspheres, and calcium hydroxyapatite (34-36).
Consisting of dextranomer microspheres (80-250 [micro]m) within a viscous matrix of stabilized sodium hyaluronate, DxHA is known to promote collagen and fibroblast formation between individual microspheres, leading to a submucosal bulking effect [3].
The study of the injection of bulking agent NASHA DX -- a dextranomer suspended in stabilised hyaluronic acid, into the anal sphincter in patients with fecal incontinence -- met the goals and demonstrated efficacy and safety.
Sorensen's report was one of a series of papers presented at a session of the AAP's Section on Urology about the use of dextranomer / hyaluronic acid (Deflux, Q-Med Scandinavia Inc.) endoscopic injection therapy for vesicoureteral reflux (VUR).
Dextranomer Microspheres (50mg/ml) or equivalent in a Carrier gel of non animal Stabilized
Containing dextranomer and hyaluronic acid (cross-linked polysaccharides), this product is currently undergoing clinical trials by Q-Med Scandinavia Inc.
Endoscopic treatment with dextranomer hyaluronic acid for complex cases of vescioureteral reflux.
Tenders are invited for Supply of Dextranomer Microspheres (Specification A prefilled Syringe of highly A viscous gel of Dextranomer microspheres (50mg/ml) or equivalent in a Carrier gel of non animal stabilized Hyaluronic acid (NASHA gel) or equivalent in a prefilled 1ml syringe to be used as endoscopic injection, It should be useful for treatment of vesicoureterixc reflux, It should be inert, safe, non toxic should not have any side effects, it should be easily injectable through a 4Fr Working Channel, It should be US FDA approved), qty 6Nos
Deflux was developed by Q-Med AB, and contains dextranomer microspheres (80-250 [micro]m) in a gel of nonanimal stabilized hyaluronic acid.
38 - dextranomer for endoscopic treatment of VUR- Task No.
Over the last decades, dextranomer hyaluronic acid (Dx/HA, Deflux, Oceana Therapeutics Ltd, Dublin, Ireland) has become the most commonly used bulking agent worldwide.